Filed: 2/13/2023ACC: 0001387131-23-001890
📋 What this filing means
AFFINITY ASSET ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 61 equity positions with a total reported market value of $254.99M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
61
Positions
$254.99M
Total AUM (reported)
37.55M
Total Shares
Allocation by class
COM$184.24M72.3%
SPONSORED ADR$22.80M8.9%
COM NEW$17.21M6.7%
COMMON STOCK$7.44M2.9%
SPONSORED ADS$5.24M2.1%
SHS$5.12M2.0%
NOTE 2.250% 2/0$3.90M1.5%
Portfolio Concentration
Top 3$54.34M21.3%
4–10$61.29M24.0%
11–25$82.88M32.5%
Rest$56.47M22.1%
Top 3 weight
21.3%
Top 10 weight
45.3%
Voting Authority Distribution
Total shares with voting rights: 37.55M
Sole
Full voting authority
37.55M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole61
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings61
Rows:
CHINOOK THERAPEUTICS INC
SOLEShares818.03K
TypeSH
Market value$21.43M
8.41%
Sole
818.03K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares70K
TypeSH
Market value$20.32M
7.97%
Sole
70K
Shared
0.00
None
0.00
BRISTOL MYERS SQUIBB CO
SOLEShares175K
TypeSH
Market value$12.59M
4.94%
Sole
175K
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares190.77K
TypeSH
Market value$12.52M
4.91%
Sole
190.77K
Shared
0.00
None
0.00
ASCENDIS PHARMA A S
SOLEShares71K
TypeSH
Market value$8.67M
3.40%
Sole
71K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares80K
TypeSH
Market value$8.28M
3.25%
Sole
80K
Shared
0.00
None
0.00
PROMETHEUS BIOSCIENCES INC
SOLEShares75K
TypeSH
Market value$8.25M
3.24%
Sole
75K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares312.50K
TypeSH
Market value$8.17M
3.20%
Sole
312.50K
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares240.62K
TypeSH
Market value$7.89M
3.09%
Sole
240.62K
Shared
0.00
None
0.00
MORPHIC HLDG INC
SOLEShares280.92K
TypeSH
Market value$7.51M
2.95%
Sole
280.92K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares240.14K
TypeSH
Market value$7.44M
2.92%
Sole
240.14K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares1.14M
TypeSH
Market value$7.17M
2.81%
Sole
1.14M
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares472.48K
TypeSH
Market value$7.04M
2.76%
Sole
472.48K
Shared
0.00
None
0.00
CEREVEL THERAPEUTICS HLDNG I
SOLEShares215K
TypeSH
Market value$6.78M
2.66%
Sole
215K
Shared
0.00
None
0.00
INARI MED INC
SOLEShares90K
TypeSH
Market value$5.72M
2.24%
Sole
90K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares600K
TypeSH
Market value$5.64M
2.21%
Sole
600K
Shared
0.00
None
0.00
MODERNA INC
SOLEShares30K
TypeSH
Market value$5.39M
2.11%
Sole
30K
Shared
0.00
None
0.00
AMGEN INC
SOLEShares20K
TypeSH
Market value$5.25M
2.06%
Sole
20K
Shared
0.00
None
0.00
HORIZON THERAPEUTICS PUB L
SOLEShares45K
TypeSH
Market value$5.12M
2.01%
Sole
45K
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares258.12K
TypeSH
Market value$5.05M
1.98%
Sole
258.12K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares110K
TypeSH
Market value$4.90M
1.92%
Sole
110K
Shared
0.00
None
0.00
BELLUS HEALTH INC NEW
SOLEShares573.68K
TypeSH
Market value$4.72M
1.85%
Sole
573.68K
Shared
0.00
None
0.00
GERON CORP
SOLEShares1.89M
TypeSH
Market value$4.58M
1.80%
Sole
1.89M
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares60K
TypeSH
Market value$4.07M
1.60%
Sole
60K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares87.60K
TypeSH
Market value$4.01M
1.57%
Sole
87.60K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CHINOOK THERAPEUTICS INCSOLE | COM | 818.03K | SH | $21.43M 8.41% | 818.03K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 70K | SH | $20.32M 7.97% | 70K | 0.00 | 0.00 |
BRISTOL MYERS SQUIBB COSOLE | COM | 175K | SH | $12.59M 4.94% | 175K | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 190.77K | SH | $12.52M 4.91% | 190.77K | 0.00 | 0.00 |
ASCENDIS PHARMA A SSOLE | SPONSORED ADR | 71K | SH | $8.67M 3.40% | 71K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 80K | SH | $8.28M 3.25% | 80K | 0.00 | 0.00 |
PROMETHEUS BIOSCIENCES INCSOLE | COM | 75K | SH | $8.25M 3.24% | 75K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADR | 312.50K | SH | $8.17M 3.20% | 312.50K | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 240.62K | SH | $7.89M 3.09% | 240.62K | 0.00 | 0.00 |
MORPHIC HLDG INCSOLE | COM | 280.92K | SH | $7.51M 2.95% | 280.92K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 240.14K | SH | $7.44M 2.92% | 240.14K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 1.14M | SH | $7.17M 2.81% | 1.14M | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 472.48K | SH | $7.04M 2.76% | 472.48K | 0.00 | 0.00 |
CEREVEL THERAPEUTICS HLDNG ISOLE | COM | 215K | SH | $6.78M 2.66% | 215K | 0.00 | 0.00 |
INARI MED INCSOLE | COM | 90K | SH | $5.72M 2.24% | 90K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 600K | SH | $5.64M 2.21% | 600K | 0.00 | 0.00 |
MODERNA INCSOLE | COM | 30K | SH | $5.39M 2.11% | 30K | 0.00 | 0.00 |
AMGEN INCSOLE | COM | 20K | SH | $5.25M 2.06% | 20K | 0.00 | 0.00 |
HORIZON THERAPEUTICS PUB LSOLE | SHS | 45K | SH | $5.12M 2.01% | 45K | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 258.12K | SH | $5.05M 1.98% | 258.12K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 110K | SH | $4.90M 1.92% | 110K | 0.00 | 0.00 |
BELLUS HEALTH INC NEWSOLE | COM NEW | 573.68K | SH | $4.72M 1.85% | 573.68K | 0.00 | 0.00 |
GERON CORPSOLE | COM | 1.89M | SH | $4.58M 1.80% | 1.89M | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 60K | SH | $4.07M 1.60% | 60K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 87.60K | SH | $4.01M 1.57% | 87.60K | 0.00 | 0.00 |
Page 1 of 3